Publication | Open Access

Immunological studies in a double blind randomized trial comparing intrapleural BCG against placebo in patients with resected stage I non-small cell lung cancer

Surgical OncologyIntrapleural BcgCell Lung CancerMedicineImmunologyClinical TrialsBronchial NeoplasmImmune Checkpoint InhibitorCancer TreatmentImmunotherapyOncologyLung CancerDouble Blind